Publications by authors named "David D Eisenstat"

Claim this Profile
I
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma.
Adrian B Levine, Julie Bennett, Prabhumallikarjun Patil, Ian Burns, Robert Siddaway, David D Eisenstat

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2021 WHO classification of tumors of the central nervous system: Responding to the challenge in low- and middle-income countries.
Michael J Sullivan, David D Eisenstat

Neurooncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation.
H Helena Wu, Sarah Leng, David D Eisenstat, Consolato Sergi, Roger Leng

Cancer Lett· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering UBE4B phosphorylation dynamics: a key mechanism in p53 accumulation and cancer cell response to DNA damage.
Yasser Abuetabh, H Helena Wu, Habib Al Yousef, Sujata Persad, Mary-Pat Schlosser, David D Eisenstat

Cell Death Discov· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Evaluation of an Educational Video to Support Consent to a Pediatric Malignancy Biobank.
Eden G Robertson, Rebecca Komesaroff, David D Eisenstat, Alexandra Robertson, Louise E Ludlow

Biopreserv Biobank· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignancies.
Shazia Adjumain, Paul Daniel, Claire Xin Sun, Gabrielle Bradshaw, Nicole J Chew, David D Eisenstat

JCI Insight· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH-mutant gliomas in children and adolescents - from biology to clinical trials.
Louise Evans, Sarah Trinder, Andrew Dodgshun, David D Eisenstat, James R Whittle

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, Nada Jabado, Adriana Fonseca, David D Eisenstat

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, Rebecca F Rogers, Yura Grabovska, David D Eisenstat

Cancer Cell· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision-guided treatment in high-risk pediatric cancers.
Loretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, Marie Wong, Paulette Barahona, David D Eisenstat

Nat Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement.
Santosh Valvi, Neevika Manoharan, Marion K Mateos, Timothy Eg Hassall, David S Ziegler, David D Eisenstat

Med J Aust· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models.
Liam M Furst, Enola M Roussel, Ryan F Leung, Ankita M George, Sarah A Best, David D Eisenstat

Biology (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A paradigm shift in how we treat pediatric low-grade glioma-Targeting the molecular drivers.
David S Ziegler, Rebecca Lehmann, David D Eisenstat

Neuro Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
Ryan J Duchatel, Evangeline R Jackson, Sarah G Parackal, Dylan Kiltschewskij, Izac J Findlay, David D Eisenstat

J Clin Invest· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learnt in the first year of an Australian pediatric cardio oncology clinic.
Claudia Toro, Ben Felmingham, Mangesh Jhadav, David S Celermajer, Andre La Gerche, David D Eisenstat

Cardiooncology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No safe harbors for recurrent posterior fossa group A ependymoma: A time for change in risk assignment?
Jordan R Hansford, David D Eisenstat

Neuro Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
Christine L White, Kathryn M Kinross, Molly K Moore, Elnaz Rasouli, Robyn Strong, David D Eisenstat

J Mol Diagn· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma.
Jiesi Zhou, Yan Shu Kong, Krista M Vincent, Dylan Dieters-Castator, Amirali B Bukhari, David D Eisenstat

Mol Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology.
Erik P Sulman, David D Eisenstat

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, Mika L Persson, Abdul Mannan, David D Eisenstat

Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.
Stacie S Wang, Alexander J Davenport, Melinda Iliopoulos, Hannah E Hughes-Parry, Katherine A Watson, David D Eisenstat

Neurooncol Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.
Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, Mika L Persson, Abdul Mannan, David D Eisenstat

Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial fused ependymoma.
Chia Huan Ng, Denise Obrecht, Olivia Wells, Michal Zapotocky, David Sumerauer, David D Eisenstat

Neurooncol Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.
Sarah M Trinder, Campbell McKay, Phoebe Power, Monique Topp, Bosco Chan, David D Eisenstat

Front Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Meningioma: From basic research to clinical translational study, volume II.
Hailiang Tang, Zhewei Shen, David D Eisenstat, Ian F Dunn

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis